“Additionally, we’ll offer TECNIS Synergy™ IOL on our new Toric II platform, when it launches later this year, to give surgeons the ability to address astigmatism at the time of surgery.” “The TECNIS Synergy™ IOL combines the best of extended depth of focus and multifocal technologies – to deliver the widest range of continuous vision with the best near vision among leading PCIOLs, 3,4,6, 7† without the visual gaps caused by existing trifocal technology,” ††† said Rajesh Rajpal, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. Over the past year, the company has received clearance or approval across North America for seven innovations designed to be used in the treatment of cataract patients, including the TECNIS Eyhance™ IOLs. The TECNIS Synergy™ and TECNIS Synergy™ Toric II IOLs are among the latest surgical vision innovations from Johnson & Johnson Vision to receive FDA and Health Canada approval. “Having used the TECNIS ® Toric II platform in other TECNIS ® lenses, I’m eager to use the TECNIS Synergy™ Toric II IOL in patients that require astigmatism correction.” Ike Ahmed,*** Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship, University of Toronto in Canada. “In the past 10 months of implanting the TECNIS Synergy™ IOL lens, I have seen excellent visual performance at all distances, and in a wide variety of lighting conditions, with most patients achieving freedom from glasses,” said Dr. 12 The rapid shift to digital platforms has increased demand from cataract patients for high-quality vision, from distance-to-intermediate-to-near, in all lighting conditions. 11 Over the last two decades, cataract patients’ visual needs have dramatically changed as digital devices have become an integral part of their daily lives. 9††Ĭataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, 10 with more than 90% of people developing cataracts by the age of 65. 1,2,3,4,8 In a company sponsored study, 9 out of 10 patients who received TECNIS Synergy™ IOL lenses did not need glasses after surgery. This next-generation PCIOL is built on the legacy TECNIS ® platform and delivers the widest range of continuous vision with the best near vision among leading PCIOLs, 3,4,6,7,8 † superior contrast even in low-light conditions, and reduced spectacle wear. Food and Drug Administration (FDA) approval of TECNIS Synergy™ and TECNIS Synergy™ Toric II IOLs, and the Health Canada approval of TECNIS Synergy™ Toric II IOLs. SANTA ANA, CA – – Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced the U.S. In a company sponsored study, 9 out of 10 patients who received TECNIS Synergy™ IOL lenses did not need glasses after surgery. Other Ingredients: Vegetarian (pullulan) capsule.Next-generation presbyopia-correcting intraocular lens (PCIOL) offers continuous vision for cataract patients across every distance regardless of lighting conditions 1,2,3,4† Organic kale & organic watercress concentrates (glucosinolates & myrosinase enzyme) SOD enzyme 140 IU (melon extract)‚ catalase fermented enzyme 1‚400 IU. SuperPure™ Flavonoid Protectors 500mg / †īlack currant extract organic aronia‚ organic elderberry & organic bilberry concentrates (anthocyanins 50mg) organic grape seed extract & wild pine bark extract (proanthocyanidins 100mg‚ polyphenols 125mg) Organic tomato extract (lycopene) organic haematococcus algae extract (astaxanthin 2mg) organic goji extract & organic sea buckthorn extract (mixed carotenes) marigold flower extract (free lutein 10mg‚ free zeaxanthin/meso-zeaxanthin 5mg) organic gardenia fruit extract & organic saffron flower extract (crocins/crocetin 3mg) SuperPure™ Carotenoid Protectors 515mg / †
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |